These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6426497)

  • 1. Effect of DDAVP on plasma levels of factor VII and XII.
    Brommer EJ; Kluft C; Bertina RM; Alderkamp GH
    Br J Haematol; 1984 May; 57(1):173-5. PubMed ID: 6426497
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of DDAVP on plasma level of factor XII.
    Nenci GG; Berrettini M; De Cunto M; Agnelli G
    Br J Haematol; 1983 Jul; 54(3):489-92. PubMed ID: 6407513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) in normal individuals (author's transl)].
    Takahashi H; Itoh M; Kobayashi I; Hattori A; Takahashi K; Sakuragawa N; Shibata A; Tsukada T
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):907-17. PubMed ID: 6785953
    [No Abstract]   [Full Text] [Related]  

  • 4. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
    Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A
    Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII-related activities after 1-deamino-8-D-arginine vasopressin in multicentric reticulohistiocytosis.
    Taddeo U; Trotta F; Menegale G; Ballerini G
    Ric Clin Lab; 1984; 14(1):37-9. PubMed ID: 6427880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
    Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
    Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intranasal DDAVP on coagulation and fibrinolytic activity in normal persons.
    Nilsson IM; Mikaelsson M; Vilhardt H
    Scand J Haematol; 1982 Jul; 29(1):70-4. PubMed ID: 6812213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New ways to boost factor VIII in hemophilia: DDAVP for mild hemophilia A, von Willebrand's.
    Marwick C
    JAMA; 1983 Jun; 249(24):3278-9. PubMed ID: 6406692
    [No Abstract]   [Full Text] [Related]  

  • 9. The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP.
    Brommer EJ; Derkx FH; Barrett-Bergshoeff MM; Schalekamp MA
    Thromb Haemost; 1984 Feb; 51(1):42-4. PubMed ID: 6426080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDAVP in uremia.
    Vicente V; Alberca I; Macias JF; Lopez Borrasca A
    Nephron; 1984; 36(2):145-6. PubMed ID: 6420716
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to fibrinolytic activity and factor VIII-related antigen to stimulation with desmopressin in hyperlipoproteinemia.
    Brommer EJ; Gevers Leuven JA; Barrett-Bergshoeff MM; Schouten JA
    J Lab Clin Med; 1982 Jul; 100(1):105-14. PubMed ID: 6806418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XII activation after DDAVP.
    Patrassi GM; Sartori MT; Lazzaro AR; Viero ML; Boscaro M; Girolami A
    Thromb Res; 1990 Jun; 58(5):531-2. PubMed ID: 2368038
    [No Abstract]   [Full Text] [Related]  

  • 13. Accumulative effect of DDAVP and heparin in increasing plasma factor VIII levels.
    Rock G; Palmer DS
    Vox Sang; 1981; 41(1):56-60. PubMed ID: 6798759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of desmopressin (DDAVP) in the preparation of improved factor VIII concentrate.
    Mikaelsson M; Nilsson IM; Cedergren B; Jonsson S; Rydberg L; Wiechel B
    Scand J Haematol Suppl; 1984; 40():93-101. PubMed ID: 6433478
    [No Abstract]   [Full Text] [Related]  

  • 15. Response of factor XII to DDAVP in patients with Hageman factor deficiency.
    Gamba G; Grignani G; Longoni P; Ascari E
    Br J Haematol; 1983 Dec; 55(4):713-5. PubMed ID: 6422975
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic induced intravascular coagulation in dogs.
    Cooper HA; Bowie EJ; Owen CA
    Am J Physiol; 1973 Dec; 225(6):1355-8. PubMed ID: 4760447
    [No Abstract]   [Full Text] [Related]  

  • 17. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    Agents Actions Suppl; 1992; 38 ( Pt 2)():292-8. PubMed ID: 1462834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDAVP: does the drug have a direct effect on the vessel wall?
    Barnhart MI; Chen S; Lusher JM
    Thromb Res; 1983 Jul; 31(2):239-53. PubMed ID: 6415852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study using immunological and biological assay of the haemostatic responses to DDAVP infusion venous occlusion and exercise in normal men.
    Prowse CV; Farrugia A; Boulton FE; Tucker J; Ludlam CA; McLaren M; Belch JJ; Prentice CR; Dawes J; MacGregor IR
    Thromb Haemost; 1984 Feb; 51(1):110-4. PubMed ID: 6426076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus.
    Kobrinsky NL; Doyle JJ; Israels ED; Winter JS; Cheang MS; Walker RD; Bishop AJ
    Lancet; 1985 Jun; 1(8441):1293-4. PubMed ID: 2860491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.